Semaglutide

Generic name: Semaglutide
Dosage form: subcutaneous injection, tablet
Drug class: Incretin mimetics

Usage of Semaglutide

Semaglutide is the active ingredient in Wegovy, Ozempic, and Rybelsus. Semaglutide is a medicine used for weight loss in specific patients, and to lower blood sugar levels and reduce the risk of major cardiovascular events such as heart attack or stroke in type two diabetes patients. Semaglutide is a GLP-1 agonist and works by increasing insulin release, lowering the amount of Glucagon released, delaying gastric emptying and reducing appetite.

Semaglutide is not for use in people with type 1 diabetes.

Semaglutide is not available as a generic medicine. Each of the different brands of semaglutide (Wegovy, Ozempic, Rybelus) are made by Novo Nordisk and are FDA approved for different conditions.

Semaglutide side effects

Get emergency medical help if you have signs of an allergic reaction: hives, itching, dizziness, fast heartbeats, difficulty breathing, swelling of your face, lips, tongue, or throat.

Serious side effects of semaglutide may include:

call your doctor at once if you have:

vision changes;

unusual mood changes, thoughts about hurting yourself;

pounding heartbeats or fluttering in your chest;

a light-headed feeling, like you might pass out;

signs of a thyroid tumor - swelling or a lump in your neck, trouble swallowing, a hoarse voice, feeling short of breath;

symptoms of pancreatitis - severe pain in your upper stomach spreading to your back, nausea with or without vomiting, fast heart rate;

gallbladder problems - upper stomach pain, fever, clay-colored stools, jaundice (yellowing of the skin or eyes);

low blood sugar - headache, hunger, weakness, sweating, confusion, irritability, dizziness, fast heart rate, or feeling jittery;

kidney problems - swelling, urinating less, feeling tired or short of breath; or

stomach flu symptoms - stomach cramps, vomiting, loss of appetite, diarrhea (may be watery or bloody).

Common side effects of semaglutide may include:

low blood sugar (in people with type 2 diabetes);

upset stomach, heartburn, burping, gas, bloating;

nausea, vomiting, stomach pain, loss of appetite;

diarrhea, constipation;

stomach flu symptoms;

headache, dizziness, tiredness.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Before taking Semaglutide

Pregnancy: Men and women should stop using semaglutide at least 2 months before you plan to get pregnant. Ask your doctor for a safer medicine to use during this time. Controlling diabetes is very important during pregnancy, as is gaining the right amount of weight. Even if you are overweight, losing weight during pregnancy could harm the unborn baby.

Breastfeeding: Ask a doctor if it is safe to breastfeed while using this Ozempic or Wegovy. You should not breastfeed while using Rybelsus.

Relate drugs

How to use Semaglutide

Ozempic dose

Ozempic injection 0.25 mg or 0.5 mg dose pen.

Pen can deliver 0.25 mg or 0.5 mg doses.

2mg/1.5mL (1.34mg/mL)

Each 1.5 ml pen contains 8 doses of 0.25mg or 4 doses of 0.5mg.

Ozempic injection 1 mg dose pen.

Pen delivers a 1mg dose.

4mg/3mL (1.34mg/mL)

Each 3ml pen contains 4 doses.

Ozempic injection 2mg dose pen.

Pen delivers a 2mg dose.

8mg/3mL (2.68 mg/mL)

Each 3ml pen contains 4 doses.

Ozempic Recommended Dosage

Start Ozempic with a 0.25 mg suBCutaneous injection (injection under the skin) once weekly for 4 weeks. The 0.25 mg dosage is intended for treatment initiation and is not effective for glycemic control.

After 4 weeks on the 0.25 mg dosage, increase the dosage to 0.5 mg once weekly.

If additional glycemic control is needed after at least 4 weeks on the 0.5 mg dosage, the dosage may be increased to 1 mg once weekly.

If additional glycemic control is needed after at least 4 weeks on the 1 mg dosage, the dosage may be increased to 2 mg once weekly. The maximum recommended dosage is 2 mg once weekly.

Administer Ozempic once weekly, on the same day each week, at any time of the day, with or without meals.

The day of weekly administration can be changed if necessary as long as the time between two doses is at least 2 days (>48 hours).

If a dose is missed, administer Ozempic as soon as possible within 5 days after the missed dose. If more than 5 days have passed, skip the missed dose and administer the next dose on the regularly scheduled day. In each case, patients can then resume their regular once-weekly dosing schedule

Wegovy dose

Strengths available:

Wegovy 0.25 mg pen delivers one 0.25 mg dose (0.25 mg/0.5 mL)

Wegovy 0.5 mg pen delivers one 0.5 mg dose (0.5 mg / 0.5 mL)

Wegovy 1 mg pen delivers one 1 mg dose (1 mg / 0.5 mL)

Wegovy 1.7 mg pen delivers one 1.7 mg dose (1.7 mg / 0.75 mL)

Wegovy 2.4 mg pen delivers one 2.4 mg dose (2.4 mg / 0.75 mL)

Wegovy Recommended Dosage

Initiate Wegovy with a dose of 0.25 mg injected subcutaneously once-weekly and follow the dose escalation schedule below to minimize gastrointestinal adverse reactions

Week 1 to week 4: 0.25mg weekly

Week 5 to week 8: 0.5mg weekly

Week 9 to week 12: 1mg weekly

Week 13 to week 16: 1.7mg weekly

Week 17 onwards: 2.4mg weekly

If patients do not tolerate a dose during dose escalation, consider delaying dose escalation for 4 weeks The maintenance dose of Wegovy is 2.4 mg injected subcutaneously once-weekly. If patients do not tolerate the maintenance 2.4 mg once-weekly dose, the dose can be temporarily decreased to 1.7 mg once-weekly, for a maximum of 4 weeks. After 4 weeks, increase Wegovy to the maintenance dose of 2.4 mg once-weekly. Discontinue Wegovy if the patient cannot tolerate the 2.4 mg dose. In patients with type 2 diabetes, monitor blood glucose prior to starting Wegovy and during Wegovy treatment.

Rybelsus dose

Rybelsus tablets strengths are available in 3mg, 7mg, and 14mg

Take Rybelsus at least 30 minutes before the first food, beverage, or other oral medications of the day with no more than 4 ounces of plain water only. After 30 minutes of taking the tablet you may eat, drink or take other oral medicines. Swallow tablets whole. Do not split, crush, or chew tablets.

Rybelsus Recommended Dosage

Start Rybelsus with 3 mg once daily for 30 days. The 3 mg dose is intended for treatment initiation and is not effective for glycemic control.

After 30 days on the 3 mg dose, increase the dose to 7 mg once daily.

Dose may be increased to 14 mg once daily if additional glycemic control is needed after at least 30 days on the 7 mg dose.

Taking two 7 mg Rybelsus tablets to achieve a 14 mg dose is not recommended.

If a dose is missed, the missed dose should be skipped, and the next dose should be taken the following day.

Switching Patients between Ozempic and Rybelsus

Patients treated with Rybelsus 14 mg daily can be transitioned to Ozempic subcutaneous injection 0.5 mg once weekly. Patients can start Ozempic the day after their last dose of Rybelsus.

Patients treated with once weekly Ozempic 0.5 mg subcutaneous injection can be transitioned to Rybelsus 7 mg or 14 mg. Patients can start Rybelsus up to 7 days after their last injection of Ozempic. There is no equivalent dose of Rybelsus for Ozempic 1 mg.

General semaglutide dosing information

Ozempic and Wegovy are injected under the skin, usually once per week at any time of the day, with or without food. Use an injection on the same day each week.

Read and follow all instructions you have been given. Ask your doctor or pharmacist if you need help.

Prepare an injection only when you are ready to give it. Call your pharmacist if the medicine looks cloudy, has changed colors, or has particles in it.

Your healthcare provider will show you where to inject semaglutide. Do not inject into the same place two times in a row.

If you choose a different weekly injection day, start your new schedule after at least 2 days have passed since the last injection you gave.

Do not use different brands of semaglutide at the same time.

Blood sugar can be affected by stress, illness, surgery, exercise, alcohol use, or skipping meals.

Low blood sugar (hypoglycemia) can make you feel very hungry, dizzy, irritable, or shaky. To quickly treat hypoglycemia, eat or drink hard candy, crackers, raisins, fruit juice, or non-diet soda. Your doctor may prescribe glucagon injections in case of severe hypoglycemia.

Tell your doctor if you have frequent symptoms of high blood sugar (hyperglycemia), such as increased thirst or urination. Ask your doctor before changing your dose or medication schedule.

Your treatment may also include diet, exercise, weight control, medical tests, and special medical care.

You may get dehydrated during prolonged illness. Call your doctor if you are sick with vomiting or diarrhea, or if you eat or drink less than usual.

Never share an injection pen, even if you changed the needle. Sharing an injection can pass infection or disease from person to person.

Store Rybelsus in the original package at room temperature, away from moisture and heat.

Store unopened Ozempic or Wegovy injection pens in the original carton in a refrigerator, protected from light. Do not use past the expiration date. Throw away an injection pen that has been frozen.

If needed, you may store an unopened Wegovy pen at cool room temperature for up to 28 days. Do not remove the cap until you are ready to use the injection pen. The pen contains a single dose. Throw the pen away after one use, even if there is still medicine left inside.

The Ozempic injection pen contains more than one dose. After your first use, store the pen with the needle removed in a refrigerator or at room temperature. Protect from heat and light. Keep the cap on when not in use. Throw the pen away 56 days after the first use or if less than 0.25 mg is shown on the dose counter.

Do not reuse a needle. Place it in a puncture-proof "sharps" container and dispose of it following state or local laws. Keep out of the reach of children and pets.

Warnings

Call your doctor at once if you have signs of a thyroid tumor, such as swelling or a lump in your neck, trouble swallowing, a hoarse voice, or shortness of breath.

You should not use semaglutide if you have multiple endocrine neoplasia type 2 (tumors in your glands), or a personal or family history of medullary thyroid cancer.

What other drugs will affect Semaglutide

Semaglutide can slow your digestion, and it may take longer for your body to absorb any medicines you take by mouth.

Tell your doctor about all your other medicines, especially insulin or other diabetes medicines, such as dulaglutide, exenatide, liraglutide, Byetta, Trulicity, Victoza, and others.

Other drugs may affect semaglutide, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell your doctor about all other medicines you use.

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.